Humacyte, Inc.
HUMA
$2.53
$0.135.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -77.67M | -148.70M | -152.87M | -139.66M | -105.70M |
| Total Depreciation and Amortization | 7.23M | 7.19M | 7.22M | 7.23M | 7.44M |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 122.00K |
| Total Other Non-Cash Items | -24.35M | 43.08M | 49.11M | 42.15M | 14.06M |
| Change in Net Operating Assets | -4.59M | 311.00K | 5.94M | 9.58M | 2.07M |
| Cash from Operations | -99.38M | -98.12M | -90.60M | -80.70M | -82.01M |
| Capital Expenditure | -1.41M | -1.57M | -1.66M | -1.22M | -1.52M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 2.11M |
| Cash from Investing | -1.41M | -1.57M | -1.66M | -1.22M | 588.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.66M | -2.58M | -2.49M | -2.41M | -34.14M |
| Issuance of Common Stock | 98.87M | 94.84M | 44.93M | 44.54M | 43.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.92M | 21.92M | 20.40M | 19.10M | 58.01M |
| Cash from Financing | 98.13M | 114.18M | 62.84M | 61.23M | 67.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.66M | 14.49M | -29.42M | -20.69M | -13.71M |